Menicon Co Ltd
TSE:7780
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 126
2 439
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Menicon Co Ltd
Menicon Co Ltd
Cash & Cash Equivalents
Menicon Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Menicon Co Ltd
TSE:7780
|
Cash & Cash Equivalents
¥40.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Hoya Corp
TSE:7741
|
Cash & Cash Equivalents
¥553B
|
CAGR 3-Years
17%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
|
H
|
Hogy Medical Co Ltd
TSE:3593
|
Cash & Cash Equivalents
¥22.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
|
Shofu Inc
TSE:7979
|
Cash & Cash Equivalents
¥9.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
Mani Inc
TSE:7730
|
Cash & Cash Equivalents
¥21.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
12%
|
|
|
Nipro Corp
TSE:8086
|
Cash & Cash Equivalents
¥83.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
1%
|
|
Menicon Co Ltd
Glance View
Menicon Co., Ltd. engages in the manufacture and sale of contact lenses. The company is headquartered in Nagoya, Aichi-Ken and currently employs 3,860 full-time employees. The company went IPO on 2015-06-25. The firm has two business segments. With its subsidiaries, the Contact Lens segment is engaged in manufacture and sales of contact lens, care supplies and other goods. The Others segment is engaged in development and sales of veterinary medical products, decomposition accelerator of rice straw, composting accelerator of livestock excrement, assisted reproductive medicine and products of advanced medical fields, as well as management of contact lens retailer staff training school and provision of temporary staffing service, among others.
See Also
What is Menicon Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
40.5B
JPY
Based on the financial report for Sep 30, 2024, Menicon Co Ltd's Cash & Cash Equivalents amounts to 40.5B JPY.
What is Menicon Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
16%
Over the last year, the Cash & Cash Equivalents growth was -19%. The average annual Cash & Cash Equivalents growth rates for Menicon Co Ltd have been 2% over the past three years , 16% over the past five years .
You don't have any saved screeners yet
